Affiliation:
1. School of Mechanical and Aerospace Engineering, Queen’s University Belfast, Belfast BT7 1NN, UK
Abstract
A three-dimensional, transient computational fluid dynamics analysis was conducted on an idealised geometry of a coronary artery fitted with representative geometries of an Absorb bioresorbable vascular scaffold (BVS) or a Xience drug-eluting stent (DES) in order to identify and compare areas of disturbed flow and potential risk sites. A non-Newtonian viscosity model was used with a transient velocity boundary condition programmed with user-defined functions. At-risk areas were quantified in terms of several parameters linked to restenosis: wall shear stress, time-averaged wall shear stress, oscillatory shear index, particle residence time, and shear rate. Results indicated that 71% of the BVS stented surface area had time-averaged wall shear stress values under 0.4 Pa compared to 45% of the DES area. Additionally, high particle residence times were present in 23% and 8% of the BVS and DES areas, respectively, with risk areas identified as being more prominent in close proximity to crowns and link struts. These results suggest an increased risk for thrombosis and neointimal hyperplasia for the BVS compared to the DES, which is in agreement with the outcomes of clinical trials. It is intended that the results of this study may be used as a pre-clinical tool to aid in the design of bioresorbable coronary stents.
Subject
Fluid Flow and Transfer Processes,Mechanical Engineering,Condensed Matter Physics
Reference51 articles.
1. Pathogenesis of atherosclerosis;Falk;J. Am. Coll. Cardiol.,2006
2. British Heart Foundation (2023, August 09). Heart and Circulatory Disease Statistics 2023. Available online: https://www.bhf.org.uk/what-we-do/our-research/heart-statistics/heart-statistics-publications/cardiovascular-disease-statistics-2023.
3. Verdonck, P. (2009). Advances in Biomedical Engineering, Elsevier. [1st ed.].
4. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents;Stone;N. Engl. J. Med.,2007
5. Bioresorbable vascular scaffolds for coronary revascularization;Kereiakes;Circulation,2016